Synopsis
Experts discuss relevant and actionable strategies for practice improvement as well as timely clinical topics.
Episodes
-
Patients With ND AML Unfit for Intensive Chemotherapy: Tailoring Treatment
31/03/2020 Duration: 20minDrs Wei and DiNardo discuss the treatment landscape for patients with ND AML who are ineligible for intensive chemotherapy. Earn Credit / Learning Objectives & Disclosures --- Full URLs: Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/927635?src=mkm_podcast_addon_927635
-
COPD: Patient Selection Based on GOLD Guidance and Response to Therapy
31/03/2020 Duration: 20minIn this against-the-clock activity, a pulmonologist and primary care physician answer key questions on dual bronchodilator therapy for COPD. Earn Credit / Learning Objectives & Disclosures --- Full URLs: Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/926217?src=mkm_podcast_addon_926217
-
CAR T-Cell Therapy in Non-Hodgkin Lymphoma and Multiple Myeloma: A Clinical Update
21/03/2020 Duration: 36minListen to the experts discuss the current and emerging role of CAR T-cell therapy in NHL and MM. Earn Credit / Learning Objectives & Disclosures --- Full URLs: Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/924229?src=mkm_podcast_addon_924229
-
Implementing Multiple Myeloma Clinical Trial Data in Real-World Practice
26/12/2019 Duration: 40minExperts in the field discuss how to implement the newest data in multiple myeloma into the real-world clinical practice. Earn Credit / Learning Objectives & Disclosures --- Full URLs: Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/923019?src=mkm_podcast_addon_923019
-
Idiopathic Pulmonary Fibrosis: The Right Treatments at the Right Time
14/12/2019 Duration: 20minDrs Vancheri and Wijsenbeek discuss the need for early treatment of IPF and the pharmacologic/non-pharmacologic options currently available. Earn Credit / Learning Objectives & Disclosures --- Full URLs: Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/921539?src=mkm_podcast_addon_921539
-
Approaching a New Era in the Management of Progressive Fibrosing ILDs
15/11/2019 Duration: 45minJoin Dr Flaherty and colleagues as they present the emerging data and clinical implications related to the use of antifibrotics in PF-ILDs. Earn Credit / Learning Objectives & Disclosures --- Full URLs: Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/920726?src=mkm_podcast_addon_920726
-
How Can We Meet the Treatment Needs of Patients With Systemic Sclerosis-Interstitial Lung Disease?
19/09/2019 Duration: 33minJoin Drs Distler and Hoffmann-Vold as they discuss current and emerging treatments for SSc-ILD and their clinical impact Earn Credit / Learning Objectives & Disclosures --- Full URLs: Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/917034?src=mkm_podcast_addon_917034
-
Working Together to Diagnose Idiopathic Pulmonary Fibrosis
20/08/2019 Duration: 33minJoin Dr Cottin and colleagues as they discuss the importance of recognizing IPF and the latest guidelines for the diagnosis. Earn Credit / Learning Objectives & Disclosures --- Full URLs: Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/916396?src=mkm_podcast_addon_916396
-
The Progressive Phenotype of Non-IPF ILD: Clinical Relevance and Identification
28/06/2019 Duration: 43minJoin Dr. Kolb and colleagues covering the etiology, pathophysiology, monitoring, and emerging treatments for non-IPF progressive fibrosing ILDs Learning Objectives & Disclosures --- Full URLs: Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/914675?src=mkm_podcast_addon_914675